TY - JOUR
KW - buprenorphine
KW - Health facilities
KW - Humans
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - access to care
KW - Medications for opioid use disorder
AU - J. Cantor
AU - D. Powell
AU - A. Kofner
AU - B. D. Stein
A1 - 
AD - RAND Corporation, 1776 Main Street, Santa Monica, CA 90401, USA. Electronic address: jcantor@rand.org.; RAND Corporation, 1200 South Hayes Street, Arlington, VA 22202, USA.; RAND Corporation, 1200 South Hayes Street, Arlington, VA 22202, USA.; RAND Corporation, 4570 Fifth Avenue, Pittsburgh, PA 15213, USA.
BT - Drug and alcohol dependence
C5 - Healthcare Disparities; Opioids & Substance Use
CP - Pt A
DO - 10.1016/j.drugalcdep.2021.109107
IS - Pt A
JF - Drug and alcohol dependence
LA - eng
M1 - Journal Article
PB - Elsevier B.V
PY - 2021
SN - 1879-0046; 0376-8716; 0376-8716
SP - 109107
T1 - Population-based estimates of geographic accessibility of medication for opioid use disorder by substance use disorder treatment facilities from 2014 to 2020
T2 - Drug and alcohol dependence
TI - Population-based estimates of geographic accessibility of medication for opioid use disorder by substance use disorder treatment facilities from 2014 to 2020
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 34656034
U3 - 10.1016/j.drugalcdep.2021.109107
VL - 229
VO - 1879-0046; 0376-8716; 0376-8716
Y1 - 2021
Y2 - Dec 1
ER -